Browse by Poster Presenter

Skip to main content

ASCPT 2024 Annual Meeting Main banner

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

S
Saleh, Ateka

Mayo Clinic
PT-002 - POST-TRANSCRIPTIONAL GENE REGULATION AND ANTIDEPRESSANT TREATMENT RESPONSE: FUNCTIONAL CHARACTERIZATION OF ELAVL2 RNA-BINDING PROTEIN IN IPSC-DERIVED NEURONS.
Ateka Saleh
Favorite
Sanga, Madhu

Janssen Research and Development LLC
PII-110 - DRUG-DRUG INTERACTION EFFECT OF STEADY STATE LAZERTINIB EXPOSURE ON THE SINGLE-DOSE PHARMACOKINETICS OF MIDAZOLAM, ROSUVASTATIN AND METFORMIN.
Madhu Sanga
Favorite
Schmith, Virginia (Ginny)

Schmith PK/PD Consulting LLC
PII-123 - METABOLIC PROFILING OF ECOPIPAM
Virginia (Ginny) Schmith
Favorite
PII-125 - MICRODOSING APPROACH TO EVALUATE WHETHER ECOPIPAM AFFECTS DRUG METABOLISM AND TRANSPORT OF CONCOMITANT MEDICATIONS
Virginia (Ginny) Schmith
Favorite
Seong, Hyeon-jeong

Inje University, College of Medicine
LB-012 - DEVELOPMENT OF LC-MS/MS METHOD FOR THE SIMULTANEOUS DETERMINATION OF ANTI-NONTUBERCULOUS MYCOBACTERIA PULMONARY DISEASE DRUGS IN HUMAN PLASMA
Hyeon-jeong Seong
Favorite
Shahin, Mohamed

Pfizer, Inc.
PII-108 - DEVELOPING A PEDIATRIC ORAL SUSPENSION FORMULATION OF ABROCITINIB: A RELATIVE BIOAVAILABILITY AND PALATABILITY ASSESSMENT STUDY IN ADULTS
Mohamed Shahin
Favorite
Sharma, Ankur

CSL Behring, King of Prussia, PA, USA
PII-142 - POPULATION EXPOSURE–RESPONSE ANALYSIS SUPPORTS EFFICACY OUTCOMES OF GARADACIMAB IN PATIENTS WITH HEREDITARY ANGIOEDEMA.
Ankur Sharma
Favorite
Shin, Maureen

University of California, San Francisco
PII-159 - THE NEED FOR EQUITABLE REPRESENTATION IN PHARMACOKINETIC STUDIES TO ENHANCE OPTIMAL DOSING STRATEGIES TO TREAT POVERTY-RELATED DISEASES IN MALNOURISHED CHILDREN.
Maureen Shin
Favorite
Shin, Wonsuk

CHA Bundang Medical Center
PII-091 - A PHASE 1 OPEN-LABEL, FIXED-SEQUENCE 3-PERIOD STUDY TO EVALUATE PHARMACOKINETIC INTERACTIONS BETWEEN FIMASARTAN AND INDAPAMIDE IN HEALTHY VOLUNTEERS
Wonsuk Shin
Favorite
Showel, Kelly

Mayo Clinic
PII-020 - EVIDENCE FOR INDUCIBLE CMV PROMOTER ACTIVITY IN HUMAN CHONDROCYTES
Kelly Showel
Favorite
Shugg, Tyler

Indiana University School of Medicine, Division of Clinical Pharmacology
PII-087 - REDUCTION OF NEXT-GENERATION SEQUENCING FILE SIZE FOR EFFICIENT PHARMACOGENOTYPE EXTRACTION.
Tyler Shugg
Favorite
So, Gerald

Indiana University
LB-009 - CANNABIDIOL INCREASES EXPOSURE OF TACROLIMUS IN HEALTHY VOLUNTEERS.
Gerald So
Favorite
PT-027 - INHIBITION OF TACROLIMUS METABOLISM BY CANNABIDIOL AND ITS METABOLITES IN VITRO.
Gerald So
Favorite
TIP-002 - DRUG-GENE-NUTRACEUTICAL INTERACTIONS OF CANNABIDIOL AND TACROLIMUS.
Gerald So
Favorite
Song, Jisoo

Seoul National University College of Medicine and Hospital
PII-155 - SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE INTRAVENOUS ADMINISTRATIONS OF LENZILUMAB IN HEALTHY KOREAN SUBJECTS
Jisoo Song
Favorite
Sperber, Nina

Durham VA Health Care System and Duke University Department of Population Health Sciences
PII-072 - A VALUE PROPOSITION FOR USING PHARMACOGENETIC TESTING IN MENTAL HEALTH CARE
Nina Sperber
Favorite
Stancil, Stephani

Children's Mercy Kansas City
PII-043 - ANTIDEPRESSANT EXPOSURE IN THE ADOLESCENT BRAIN: FLUOXETINE AND PHARMACOGENETIC INFLUENCES ON BRAIN DISPOSITION
Stephani Stancil
Favorite
Stern, Sydney

U.S. Food and Drug Administration
PII-180 - CLINICAL PHARMACOLOGY CONSIDERATIONS FOR FIRST-IN-HUMAN CLINICAL TRIALS FOR ENZYME REPLACEMENT THERAPY
Sydney Stern
Favorite
Stewart, Clinton

St. Jude Children's Research Hospital
LB-025 - PHARMACOKINETICALLY-GUIDED DOSING OF ORAL SORAFENIB IN PATIENTS WITH PEDIATRIC HEPATOCELLULAR CARCINOMA
Clinton Stewart
Favorite
Stocco, Gabriele

University of Trieste / Institute for Maternal and Child Health IRCCS Burlo Garofolo
PII-203 - KLEBSIELLA PNEUMONIAE CONTRIBUTES TO REDUCE THIOPURINES CYTOTOXICITY IN VITRO: POSSIBLE IMPLICATIONS OF BACTERIAL METABOLISM
Gabriele Stocco
Favorite
Storelli, Flavia

Pfizer
PII-070 - TUCATINIB DOES NOT INCREASE PACLITAXEL PLASMA CONCENTRATIONS IN PATIENTS WITH HER2+ GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Flavia Storelli
Favorite
Sun, Boguang

University of Minnesota College of Pharmacy
AI-002 - APPLICATION OF MACHINE LEARNING COMBINED WITH POPPK AND QSP MODELS FOR ADVERSE EVENTS RISK PREDICTION OF A CD19-TARGETING BISPECIFIC THERAPY
Boguang Sun
Favorite
PT-007 - APPLICATION OF MACHINE LEARNING COMBINED WITH POPPK AND QSP MODELS FOR ADVERSE EVENTS RISK PREDICTION OF A CD19-TARGETING BISPECIFIC THERAPY
Boguang Sun
Favorite
Sun, Wei-Jhe

Division Of Therapeutic Performance II, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
LB-001 - A GENERIC TACROLIMUS CAPSULE SHOWN NOT TO BE BIOEQUIVALENT TO THE BRAND TACROLIMUS CAPSULE IN A POST-APPROVAL PHARMACOKINETIC BIOEQUIVALENCE STUDY IN HEALTHY SUBJECTS
Wei-Jhe Sun
Favorite
Suram, Anitha

Blueprint Medicines Corporation
PII-173 - LEVERAGING PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING AND CLINICAL DATA TO PREDICT DRUG-DRUG INTERACTIONS (DDI) OF AVAPRITINIB AND GUIDE DOSE ADJUSTMENTS.
Anitha Suram
Favorite